Benjamin F. Edwards & Company Inc. reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,573 shares of the healthcare conglomerate’s stock after selling 69 shares during the quarter. Benjamin F. Edwards & Company Inc.’s holdings in UnitedHealth Group were worth $292,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also bought and sold shares of UNH. State Street Corp increased its holdings in UnitedHealth Group by 2.5% during the 1st quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock valued at $7,499,276,000 after acquiring an additional 1,122,534 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in shares of UnitedHealth Group by 29.9% during the 1st quarter. Ameriprise Financial Inc. now owns 3,332,761 shares of the healthcare conglomerate’s stock worth $546,574,000 after purchasing an additional 766,573 shares during the last quarter. Swiss National Bank boosted its stake in shares of UnitedHealth Group by 25.8% during the 1st quarter. Swiss National Bank now owns 3,719,488 shares of the healthcare conglomerate’s stock worth $610,033,000 after purchasing an additional 763,161 shares during the last quarter. Karp Capital Management Corp acquired a new stake in shares of UnitedHealth Group during the 1st quarter worth about $113,729,000. Finally, Old Mutual Global Investors UK Ltd. acquired a new stake in shares of UnitedHealth Group during the 1st quarter worth about $109,807,000. Hedge funds and other institutional investors own 86.21% of the company’s stock.
Shares of UnitedHealth Group Incorporated (NYSE UNH) opened at 197.75 on Monday. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $200.44. The company has a market cap of $191.20 billion, a price-to-earnings ratio of 23.76 and a beta of 0.63. The company has a 50 day moving average of $194.18 and a 200-day moving average of $179.36.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, beating analysts’ consensus estimates of $2.38 by $0.08. The business had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. UnitedHealth Group’s revenue was up 7.7% on a year-over-year basis. During the same period in the prior year, the company posted $1.96 earnings per share. On average, equities research analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Friday, September 8th will be paid a $0.75 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s payout ratio is 35.13%.
In related news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the transaction, the director now directly owns 60,834 shares in the company, valued at $12,135,774.66. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction on Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the transaction, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The disclosure for this sale can be found here. Insiders sold 25,600 shares of company stock valued at $4,962,694 over the last 90 days. 0.89% of the stock is currently owned by corporate insiders.
WARNING: “Benjamin F. Edwards & Company Inc. Sells 69 Shares of UnitedHealth Group Incorporated (UNH)” was first posted by Markets Daily and is owned by of Markets Daily. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.themarketsdaily.com/2017/09/11/benjamin-f-edwards-company-inc-sells-69-shares-of-unitedhealth-group-incorporated-unh.html.
Several equities research analysts have issued reports on the stock. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Cantor Fitzgerald reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Tuesday, August 29th. UBS AG reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. Jefferies Group LLC reaffirmed a “buy” rating and set a $215.00 price target on shares of UnitedHealth Group in a research note on Friday, August 18th. Finally, Morgan Stanley raised their price target on shares of UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Thursday, August 17th. One research analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $203.41.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.